Niche CRO Surpass operates as a specialized preclinical CRO with expertise in surgical and interventional procedures, GLP studies, and human cadaver testing, presenting a clear value proposition for medical device, pharma, and biotech clients seeking rigorous preclinical validation.

Accreditations & Compliance With AAALAC accreditation, OLAW assurance, NIH involvement, and DOD safety readiness, Surpass signals strong regulatory compliance and government-funded work potential, appealing to clients requiring robust quality and audit readiness.

Expanded Capabilities Facilities in the Midwest with hospital-grade equipment and specialized imaging and support technologies enable end-to-end preclinical testing, design support, human factors, and training studies, offering cross-sell opportunities to device and combination product companies.

Awarded Credibility Recurring CRO Leadership Awards for quality, regulatory, innovation, and reliability bolster credibility for prospects considering outsourcing, potentially easing risk perceptions and shortening sales cycles.

Growth through Partnership Small-to-mid sized client focus (startups to established firms) combined with flexible engagement models positions Surpass to pursue partnerships for early feasibility through development milestones, enabling long-term contracts and ongoing research programs.